IDEXX Laboratories Inc (IDXX)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	887,867	866,239	845,629	866,567	845,042	822,728	791,435	699,178	679,089	669,653	663,950	734,553	744,845	756,864	727,848	674,206	581,776	497,482	460,100	436,866
Revenue (ttm)	US$ in thousands	3,897,506	3,844,819	3,784,803	3,724,853	3,660,953	3,587,920	3,514,054	3,430,970	3,367,324	3,339,846	3,308,606	3,274,202	3,215,360	3,135,208	3,046,576	2,858,026	2,706,655	2,591,163	2,474,677	2,457,188
Net profit margin		22.78%	22.53%	22.34%	23.26%	23.08%	22.93%	22.52%	20.38%	20.17%	20.05%	20.07%	22.43%	23.17%	24.14%	23.89%	23.59%	21.49%	19.20%	18.59%	17.78%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $887,867K ÷ $3,897,506K
= 22.78%

IDEXX Laboratories Inc's net profit margin has shown a consistent upward trend from March 31, 2020, to December 31, 2021, reaching a high of 24.14%. However, there was a slight decline in the net profit margin in the following quarters, stabilizing around the range of 20% to 23% from March 31, 2022, to December 31, 2024. This indicates that the company has been effectively managing its costs and expenses relative to its revenue during this period. The fluctuations within the 20% to 23% range suggest that IDEXX Laboratories Inc has been maintaining a healthy level of profitability despite some variability. Further monitoring of the net profit margin will be important to assess the company's financial performance in the future.